IKBKE inhibits TSC1 to activate the mTOR/S6K pathway for oncogenic transformation

Upon activation by various stimuli, PI3K/AKT or similar effectors can relieve the inhibitory effect of the TSC1/TSC2 complex through their phosphorylation to favor mTOR/S6K activation in the downstream.